
Khushi Patel
PharmD
Khushi Patel is a Pharm.D professional with a strong foundation in clinical pharmacy, patient-centered care, regulatory affairs, and pharmacovigilance, with published work on Brugada syndrome. Her interests include regulatory affairs, pharmacovigilance, guideline integration, multimodal therapy, pharmacogenomics, and antibiogram utilization, with a focus on evidence-based clinical decision-making and medication safety. As a Pharmacally healthcare writer, she translates clinical and scientific evidence into clear, accurate, and clinically relevant healthcare content, while continuously developing her expertise in evolving pharmacy practice.
About Khushi
Khushi Patel (PharmD) is a writer at Pharmacally, with 43 published articles, each checked against primary sources by our editorial team.
Articles by Khushi Patel
Health TidingsCytoSorb Real-World Data Show 37% Reduction in Severe Bleeding During Urgent CABG
Health TidingsLilly to Acquire Merida Biosciences for Up to $2.875 Billion to Advance Precision Autoantibody Therapies
New Drug ApprovalNew Hope for Polycythemia Vera: FDA Approves MIMRYLO
Health TidingsPeptron Advances PT403 Into Phase 1 Development as Once-Monthly Semaglutide Formulation
Health TidingsFDA Extends Deramiocel Review to November 2026 as Capricor Refines DMD Indication
Health TidingsGossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Review in PAH
Health TidingsKaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Trial
A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala